Johnson & Johnson Inc has launched its recommended offer for Crucell NV at €24.75 per share for all of the shares it does not already own. The price is the same as that announced on 17 September, 2010 when the offer was first disclosed. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
